AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04681937 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Subacromial Injection (Serum Saline) + Physical Therapy.
Description: arm1: sodium hyaluronate (4ml) arm2: platelet-rich-plasma (4ml) arm3: methylprednisolone acetate (1ml methylprednisolone acetate + 3 ml serum saline) arm4: serum saline (4ml) The same physical therapy procedure will be applied to all arms after injection.
Study NCT01093300 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting balloon catheter
Study NCT01093300 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Everolimus-eluting stent
Study NCT04468243 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse-led diabetes care
Description: Nurse-led brief diabetes education, instructions on glucometer and Metformin use, patients receive prescriptions for Metformin and blood glucose testing kit
Study NCT06561542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LX22001 for Injeciton
Description: single dose: 25mg,50mg,100mg,200mg ,intravenous infusion. repeat doses: 50mg,100mg , intravenous infusion,once daily for 3 days.
Study NCT06561542 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tegoprazan tablet
Description: 50mg,oral,single dose
Study NCT06561542 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole sodium for injection
Description: 80 mg intravenous infusion for 30 min followed by a continuous infusion of 8 mg/h for 71.5h
Study NCT05120388 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Extra Virgin Olive Oil Addition
Description: Daily dietary addition of olive oil (three tablespoons)
Study NCT06089057 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pro-social Power training Activity for Aging and Well-being with Chronic Kidney Disease
Description: This is a 16-week power-training and physical activity-focused intervention that contains group in-center and individual at-home components and motivational coaching. Participants will meet 2-3 times per week for the in-center power training. Participants will also be asked to wear accelerometers at home in order for their physical activity frequency to be measured.
Study NCT06089057 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention Control for Pro-social Power training Activity for Aging and Well-being with Chronic Kidney Disease
Description: This will be the attention control arm that will involve receipt of a physical activity education booklet, use of an accelerometer, and weekly check-in calls. No power training or motivational coaching will be delivered.
Study NCT05507489 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Jinzhen oral liquid or Jinhuaqinggan granules
Description: Jinzhen oral liquid, for 3 years old, 10 ml once, twice a day; for 4 to 7 years old, 10 ml a time, 3 times a day; for 8 to 18 years old, 15 ml a time, 3 times a day.The dosage and usage of Jinhua Qinggan granules were determined by the researcher according to the patient's condition. The drugs were medicated for 14 days.
Study NCT05507489 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jinzhen oral liquid or Jinhuaqinggan granules
Description: Jinzhen oral liquid, for 3 years old, 10 ml once, twice a day; for 4 to 7 years old, 10 ml a time, 3 times a day; for 8 to 18 years old, 15 ml a time, 3 times a day.The dosage and usage of Jinhua Qinggan granules were determined by the researcher according to the patient's condition. The drugs were medicated for 14 days.
Study NCT05536674 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMS reminder for the HPV vaccination
Description: A BI-informed SMS reminder to remind caregivers of girls between 10-12 years that their daughter is due the first dose of her HPV vaccination and share information about the vaccine.
Study NCT05053360 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healing Touch
Description: Healing Touch (HT), with a foundation in holistic nursing, is a gentle therapy that uses touch to promote health and well-being by balancing the human energy system. Healing Touch (HT) is a biofield therapy in which practitioners use their hands in a heart-centered and intentional way to provide energetic balance to support physical, emotional, mental and spiritual health. It is safe for all ages and works in harmony with, is complementary to, and may be integrated with standard medical care. Healing Touch is a collection of standardized, noninvasive techniques that clear, energize, and balance the human and~environmental energy fields.
Study NCT05053360 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Quiet Time (QT) session is when a subject is provided with quiet for 15 minutes
Study NCT06250153 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: m-SBIRT (mobile-Screening, Brief Intervention, and Referral to Treatment)
Description: M-SBIRT is a mobile phone-based program designed to enhance delivery of Screening, Brief Intervention, and Referral to Treatment (SBIRT), an evidence-based approach for mental health and substance use screening and treatment. The program utilizes mobile phone text message-based screenings with immediate automated feedback, paired with remote care coordination and, if appropriate, referral to substance use disorder treatment services.
Study NCT05206227 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: Subjects will complete a single bout of aerobic exercise.
Study NCT05206227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: alpha-FMH
Description: Subjects will undergo either local heating with diathermy or whole body heating with far-infrared sauna.
Study NCT05206227 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance and Aerobic Exercise
Description: Subjects will complete bouts of resistance and aerobic exercise.
Study NCT05206227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antihistamine
Description: Subjects will complete a single bout of aerobic exercise under placebo vs antihistamine conditions.
Study NCT04746872 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Alinity m HR HPV
Description: A qualitative in vitro test that amplifies and detects HR HPV DNA in cervical tissue samples.
Study NCT04757740 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: intra-articular Platelet rich fibrin and lidocaine
Description: intra-articular injection of 3.5 ml of 1% lidocaine and PRF mixture.
Study NCT04757740 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: methylprednisolone acetate and lidocaine
Description: intra-articular injection of Mixture of 40 mg of methylprednisolone acetate(1 ml) and 1% lidocaine (2.5 ml). intra-articular steroid
Study NCT06515067 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: back massage
Description: back massage
Study NCT06515067 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: no ıntervention
Description: no ıntervention
Study NCT06184763 — intervention group
Intervention type: OTHER
Intervention: 6-minute walk test
Description: 6-minute walk test in a 40-metre corridor. Included patients are used to performing this test, which is part of the standard care performed during patient follow-up, at least once a year.~Parameters collected during the test: distance walked, minimum SpO2, average SpO2, maximum heart rate, average heart rate, average heart rate over the last 2 minutes, dyspnea scale.
Study NCT06572033 — intervention group
Intervention type: BEHAVIORAL
Intervention: Simulation
Description: Observational study with simulations.
Study NCT06446362 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IMCHB-Based Breastfeeding Support Program
Description: This intervention includes a structured breastfeeding support program based on the Interaction Model of Client Health Behavior (IMCHB). It consists of:~Educational Sessions: Conducted during the last trimester of pregnancy to provide information and prepare mothers for breastfeeding.~Motivational Interviews: Conducted face-to-face at 1-3 days, 15 days, 30 days, 45 days, and 60 days postpartum to address individual challenges and provide personalized support.~Follow-Up Support: Two follow-up sessions via WhatsApp video calls at 4 and 5 months postpartum to reinforce the intervention and provide ongoing assistance.
Study NCT06446362 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Breastfeeding Education
Description: Participants receive the standard care provided at Family Health Centers, which includes routine breastfeeding education and support typically offered to new mothers. This standard care does not include the additional structured support interventions provided in the IMCHB-Based Breastfeeding Support Program.
Study NCT06295120 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin 1.2 MIE 4 times daily
Description: The intervention is the duration of treatment with phenoxymethylpenicillin from 3 to 7 days. Dose and frequency of the treatment is the same in the different arms.
Study NCT04706637 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evogliptin
Description: evogliptin 5mg + metformin, oral administration once a day for 48 weeks
Study NCT04706637 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin
Description: dapagliflozin 10mg + metformin, oral administration once a day for 48 weeks
Study NCT05614453 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab is an investigational, humanised-IgG4 monoclonal antibody with high affinity/binding specificity for PD-1. It is engineered to minimise binding to FcγR on macrophages to abrogate antibody-dependent cellular phagocytosis.
Study NCT05614453 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sitravatinib
Description: Sitravatinib is an orally bioavailable receptor tyrosine kinase (RTK) inhibitor with potential anti-neoplastic activity.
Study NCT04999280 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fiber Croissant (FIBCRO) Group
Description: Subjects will consume for 2 weeks at breakfast a fiber-enriched sourdough croissant. All subjects will be requested not to change other dietary habits and their physical activity during the 2 week intervention period.
Study NCT04999280 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Croissant (CONCRO) Group
Description: Subjects will consume for 2 weeks at breakfast a sourdough croissant. All subjects will be requested not to change other dietary habits and their physical activity during the 2 week intervention period.
Study NCT05869136 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: microneedling and hyaluronic acid for increasing gingival thickness in thin gingival phenotype
Description: All the participants will undergo phase-I therapy. Oral hygiene instructions will be imparted and will be reinforced at each appointment.~Local anaesthesia in the form of xylocaine spray will be administered.~Hyaluronic acid:~HA will be injected in the attached gingiva and MN will be carried out 1mm below the gingival margin on the keratinized gingiva of the tooth to be treated with thirty-gauge (0.255 mm) lancet needles in the test group.
Study NCT05869136 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: microneedling for increasing gingival thickness in thin gingival phenotype
Description: All the participants will undergo phase-I therapy. Oral hygiene instructions will be imparted and will be reinforced at each appointment.~Local anaesthesia in the form of xylocaine spray will be administered and microneedling alone will be performed in control group
Study NCT06558812 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: prefabricated space maintainer
Description: i. Prefabricated band will be selected for the abutment tooth by measuring the mesiodistal diameter of the abutment tooth with a caliper and will be adjusted with the internal diameter of the prefabricated band.~ii. The loop will be selected based on the available mesiodistal space and buccolingual width of the abutment tooth, excessive length with be cut by cutting plier and will then place inside the band's tube by using a HOWE pliers.~iii. Cotton roll isolation will use, then will be cemented with glass ionomer,
Study NCT06558812 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: conventional space maintainer
Description: i. A full arch Impressions will be taken with alginate material. ii. Impressions will be poured up using dental stone within 30 min of the impression taking.~iii. The children will be given an appointment for space maintainer insertion. iv. In the second visit , Cotton roll isolation will use, cementation will be performed with glass ionomer .
Study NCT05576831 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Re-excision
Description: Re-excise (one take back only) Excise scar aiming for 1-2cm margin
Study NCT06563063 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flumazenil
Description: The dose determination for flumazenil followed a biased-coin up-and-down design. Starting with an initial dose of 5 mcg, if there was an improvement in respiratory distress, the biased-coin method was used to give the same dose in the next patient with a probability of 8/9, and a decreased dose of 5 mcg in the next patient with a probability of 1/9.
Study NCT06430294 — intervention group
Intervention type: OTHER
Intervention: Spinal mobilisation
Description: Application of a force on pediatric manikins.
Study NCT06062823 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afatinib 40 MG
Description: Afatinib 40mg administered orally daily.
Study NCT05392959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg Tab
Description: Dapagliflozin 10 mg per day
Study NCT05392959 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for dapagliflozin film-coated tablets 10 mg
Study NCT05150223 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional strength training
Description: traditional strength training (running, jumping forward over a barrier with one leg and two legs, heel-rise, push up and ball throw with load, bench press, and flexion-abduction-external rotation pattern with theraband). Participation in the traditional strength training group will complete these exercises with a load and without time limitations and speed.
Study NCT05150223 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Power training
Description: progressive functional strength training protocol (running, jumping forward over a barrier with one leg and two legs, heel-rise, push up and ball throw with load, bench press, and flexion-abduction-external rotation pattern with theraband)
Study NCT04579653 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcutaneous electrical nerve stimulation devices
Description: electrical stimulation through surface electrodes
Study NCT04579653 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcutaneous electrical nerve stimulation devices
Description: electrical stimulation through surface electrodes
Study NCT04693611 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individual cognitive stimulation therapy (iCST)
Description: The intervention group will receive 24 individual CS sessions per participant. Each session will last approximately 45 minutes and will have the following structure: session introduction (5 minutes); reality orientation (10 minutes); stimulation of cognitive domain (25 minutes); session closure (5 minutes). The sessions will be led by a previously trained therapist. The intervention program will include several activities based on the principles of CS and adjusted for participants without any neurocognitive disorder.
Study NCT04693611 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Functional near-infrared spectroscopy (fNIRS)
Description: The acquisition by fNIRS will be performed in each CS session in four regions of interest (ROIs) in the prefrontal cortex: left dorsolateral prefrontal cortex (LDLPFC); left medial prefrontal cortex (LMPFC); right medial prefrontal cortex (RMPFC); right dorsolateral prefrontal cortex (RDLPFC).
Study NCT05366582 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Macintosh Laryngoscope
Description: After the induction, laryngoscopy will be performed with a Macintosh laryngoscope after 2 minutes of manual ventilation after muscle relaxant by an anesthesiologist with at least 4 years of experience. Patients will be intubated with the Medtronic Xomed Nerve Integrity Monitor Standard Reinforced ElectromyographyEndotracheal Tube (size 6.0, 7.0 or 8.0). The cuff of the intubation tube will be connected to a manometer and inflated at a pressure of 20-30 mmHg until there is no air leak. Intubation will be confirmed by the appearance of end-tidal carbon dioxide (CO2). Failed intubation will be considered if not achieved within 2 minutes
Study NCT06028100 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sacral erector spinae plane block
Description: espb from bilateral sacral level 2 with 20 ml %0,25 bupivacaine
Study NCT03549403 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient-centered telephone education
Description: The intervention will be carried out in accordance with the guidelines and the contents of the patient-centered telephone education intervention in the same way with every patient. The education call duration is approximately 15 to 30 minutes.
Study NCT06111391 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Osstell® device (Integration Diagnostics Ltd.).
Description: After trans-mucosal abutments were removed and the smart pegs were attached to the fixtures, resonance frequency analysis was done to assess implant stability.The implant stability quotient (ISQ) was used to quantify stability via the Osstell® device (Integration Diagnostics Ltd.).
Study NCT05837143 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: JV001
Description: JV001 (AAV9/modTERT) will be delivered by a percutaneous method in the catheter laboratory. Dose: 2×10\^11vg/kg，or 6×10\^11vg/kg.
Study NCT05532787 — intervention group
Intervention type: OTHER
Intervention: Application of acute chest pain risk stratification scores (HEART and EDACS)
Description: Collection of data elements for the HEART Pathway and EDACS-ADP assessments and calculation of scores to risk stratify patients into low risk or high risk
Study NCT05222490 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Thermal Camera images acquisition - FeetSee
Description: Thermal images will be collected according to the instructions for use of the Feetsee device.
Study NCT05222490 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thermal Camera images acquisition - FeetSee
Description: Thermal images will be collected according to the instructions for use of the Feetsee device.
Study NCT05222490 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Thermal Camera images acquisition - Reference
Description: After 15 minutes of resting, thermal images from the reference device will be collected according to their manufacturer
Study NCT05222490 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thermal Camera images acquisition - Reference
Description: After 15 minutes of resting, thermal images from the reference device will be collected according to their manufacturer
Study NCT04706117 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Self-retaining bicanalicular intubation stent
Description: self-retaining bicanaliculs intubation setII(SRSII) which is the latest innovation in the field as these silicone stent segments traverse both canaliculi till the lacrimal sac. In which each end of this semicircular device has 2 stout angulated wings/flanges which pose no resistance while proceeding forward into the canaliculus, but once they get into open cavity (lacrimal sac), the flanges open up and give resistance to their removal against the common canalicular opening
Study NCT06314620 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin saline lock
Description: Participants with intercostal chest catheter who underwent normal saline flushing with heparin saline lock
Study NCT06314620 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Without heparin saline lock
Description: Participants with intercostal chest catheter who underwent normal saline flushing without heparin saline lock
Study NCT06386731 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Intermittent Phototherapy
Description: 2-hour phototherapy application in the intervention group
Study NCT06386731 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intermittent Phototherapy
Description: 2-hour phototherapy application in the intervention group
Study NCT05993182 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ephedrine 5mg
Description: Patients received 5mg bolus dose of ephedrine Intravenous after the first hypotension \[ Base line time or starting point is first hypotension\]
Study NCT05993182 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ephedrine 10mg
Description: Patients received 10mg bolus dose of ephedrine Intravenous after the first hypotension \[ Base line time or starting point is first hypotension\]
Study NCT05993182 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ephedrine 15mg
Description: Patients received 15mg bolus dose of ephedrine Intravenous after the first hypotension \[ Base line time or starting point is first hypotension\]
Study NCT06295120 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phenoxymethylpenicillin 1.2 MIE 4 times daily
Description: The intervention is the duration of treatment with phenoxymethylpenicillin from 3 to 7 days. Dose and frequency of the treatment is the same in the different arms.
Study NCT06305559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: obicetrapib 10 mg + ezetimibe 10 mg FDC daily
Description: Active treatment
Study NCT06305559 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Baseline lipid modifying therapy